PLoS ONE (Jan 2013)

Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.

  • Mathieu Nacher,
  • Celia Basurko,
  • Antoine Adenis,
  • Emilie Gaubert-Marechal,
  • Emilie Mosnier,
  • Sophie Edouard,
  • Vincent Vantilcke,
  • Sindou Sivapregassam,
  • Benoit Tressières,
  • André Cabié,
  • Pierre Couppié

DOI
https://doi.org/10.1371/journal.pone.0080187
Journal volume & issue
Vol. 8, no. 11
p. e80187

Abstract

Read online

A retrospective cohort study was conducted on 1541 HIV-infected patients to determine variables associated with the incidence of herpes zoster. A single failure Cox model showed that herpes zoster incidence increased following the first 6 months of antiretroviral treatment adjusted hazard ratio (AHR)=5 (95%CI=2.6-9.2), P60 years age group AHR=2 (95%CI=1-4), P=0.04; in patients in the top CD8 quartile AHR=2.1 (95%CI=1.3-3.6), P<0.001; and in patients previously reported to use crack cocaine AHR=5.9, (95%CI=1.4-25), P=0.02. Herpes zoster incidence increased in patients with CD4 counts<500 per mm(3) and gradually declined since 1992-1996, with AHR=0.3 (95%CI=0.2-0.5), P<0.001 for the 1997-2002 period and AHR=0.24 (95%CI=0.14-0.4), P<0.001 for the 2002-2008 period. Contrary to what has been described elsewhere, there was no specific effect of protease inhibitors on herpes zoster incidence. The present study is the first to suggest that crack cocaine is associated with an increased incidence of herpes zoster. The neurological or immunological effects of crack are discussed.